Table 1. Demographics and disease characteristics of patients with HCC.

Characteristics			Frequency	Percent
Total (n)			316
Age (years)	Median (IQR)		60 (54–67)
Gender	Male		245	77
	Female		71	23
Comorbidities	None		162	50
	Multiple		76	24
	Diabetes		34	11
	Hypertension		34	11
	Other		10	3.2
Underlying risk factors for HCC	Hepatitis C		187	59
	Hepatitis B		37	11
	Other non-viral causes		19	6
	Unknown (likely non alcoholic fatty liver disease)		78	24
Performance status: ECOG	0		136	43
	1		130	41
	2		36	11.4
	3		13	4
	4		1	0.6
Mode of presentation	Abdominal pain		151	52
	Jaundice		8	2.5
	Weakness and weight loss		39	12.34
	Ascites		59	18.7
	Upper GI bleed		38	12
	Encephalopathy		11	3.5
	Other symptoms		5	1.6
	Incidental diagnosis		20	7
	Diagnosis on screening		6	2
Laboratory values	Median platelet per cubic millimeter (Median/IQR)		144 (91–214)
	Total bilirubin g/dL (Median/range)		1 (0.6–1.7)
	International normalised ratio – INR (Median/range)		1.1 (1.05–1.3)
	Serum albumin g/dl (Median + SD)		3.4 (2.9 + 3.9)
	Alpha fetoprotein – AFP ng/mL (Median/IQR)		42 (6–627)
Radiological findings	Median tumour size in cm (IQR) (n = 281)		5.4 (2.6–10)
	No. of lesions (n = 303)	1	166	54.7
		2–3	64	21
		>3	73	24
	Underlying cirrhosis		270	85.4
	Extrahepatic involvement of HCC		39	12.3
	Presence of PVT		98	31
Child–Pugh class	A		216	68.4
	B		76	24
	C		24	7.6
MELD score	6–16		289	91.4
	17–40		21	6.6
BCLC staging	0		17	5.4
	A		91	28.8
	B		64	20.3
	C		123	39
	D		10	3.2